Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma

Hanna Saadani; Bernies van der Hiel; Else A. Aalbersberg; Ioannis Zavrakidis; John B.A.G. Haanen; Otto S. Hoekstra; Ronald Boellaard; Marcel P.M. Stokkel

doi:10.2967/jnumed.119.228312

Research ArticleOncology

Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma

Hanna Saadani, Bernies van der Hiel, Else A. Aalbersberg, Ioannis Zavrakidis, John B.A.G. Haanen, Otto S. Hoekstra, Ronald Boellaard and Marcel P.M. Stokkel

Journal of Nuclear Medicine November 2019, 60 (11) 1545-1552; DOI: https://doi.org/10.2967/jnumed.119.228312

Hanna Saadani

1Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bernies van der Hiel

1Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Else A. Aalbersberg

1Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ioannis Zavrakidis

2Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John B.A.G. Haanen

3Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Otto S. Hoekstra

4Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ronald Boellaard

4Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcel P.M. Stokkel

1Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 60, Issue 11

November 1, 2019

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma

Hanna Saadani, Bernies van der Hiel, Else A. Aalbersberg, Ioannis Zavrakidis, John B.A.G. Haanen, Otto S. Hoekstra, Ronald Boellaard, Marcel P.M. Stokkel

Journal of Nuclear Medicine Nov 2019, 60 (11) 1545-1552; DOI: 10.2967/jnumed.119.228312

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma

Hanna Saadani, Bernies van der Hiel, Else A. Aalbersberg, Ioannis Zavrakidis, John B.A.G. Haanen, Otto S. Hoekstra, Ronald Boellaard, Marcel P.M. Stokkel

Journal of Nuclear Medicine Nov 2019, 60 (11) 1545-1552; DOI: 10.2967/jnumed.119.228312

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

The Dark Side of Radiomics: On the Paramount Importance of Publishing Negative Results
This Month in JNM

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Oncology

Chimeric antigen receptor (CAR) T cells Imaging: Clinical Needs and Strategies for Success
Metastatic NUT Midline Carcinoma
Radionuclides used in Nuclear Therapeutic Medicine: a brief history, properties and main relevant studies of radionuclides with mass number less than 100

Show more Oncology

Clinical

Chimeric antigen receptor (CAR) T cells Imaging: Clinical Needs and Strategies for Success
Metastatic NUT Midline Carcinoma
Radionuclides used in Nuclear Therapeutic Medicine: a brief history, properties and main relevant studies of radionuclides with mass number less than 100

Show more Clinical

Keywords

18F-FDG PET/CT
melanoma
BRAF
radiomics

Main menu

User menu

Search

Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Oncology

Clinical

Similar Articles

Keywords